Erysipelas of the upper extremity following locoregional therapy for breast cancer

Breast

Volumn 14, Issue 5, 2005, Pages 347-351

  El Saghir, Nagi S ^a   Otrock, Zaher K ^a   Bizri, Abdul Rahman N ^a   Uwaydah, Marwan M ^a   Oghlakian, Gerard O ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Antibiotics; Breast cancer; Erysipelas; Lymphedema

Indexed keywords

ANTINEOPLASTIC AGENT; CEFALOTIN; CEFAZOLIN; CLINDAMYCIN; PENICILLIN G; PENICILLIN V;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BETA HEMOLYTIC STREPTOCOCCUS; BREAST CANCER; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; ERYSIPELAS; FEMALE; HUMAN; INFECTION RISK; LYMPH NODE DISSECTION; LYMPHEDEMA; MASTECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SKIN EXFOLIATION; TREATMENT OUTCOME;

EID: 27144515635     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.02.011     Document Type: Article

References (12)

1. D.L. Stevens Infections of the skin, muscle, and soft tissues. In: A.S. Fauci E. Braunwald K.J. Isselbacher, editors. Harrison's principles of internal medicine 14th ed 1998 McGraw-Hill New York 827-30
2. K. Keinert U. Schalldach E. Schumann The erysipelas as complication of a lymph oedema after therapy of mastocarcinomas (author's transl) Strahlentherapie 157 1981 91-3 [in German]
3. F.J. Van den Wildenberg L.J. Strobbe Diagnostic image (180). A woman with painful erythema after breast-conserving surgery. Erysipelas caused by group B Streptococcus agalactiae Ned Tijdschr Geneeskd 148 2004 524 [in Dutch]
4. H. Ben Salah W. Siala I. Maaloul F. Bouzid M. Frikha J. Daoud Erysipelas after breast cancer treatment Tunis Med 80 2002 465-8 [in French]
5. P. Jego S. Resche C. Karacatsanis A. Le Strat J. Bouget J. Minet B. Grosbois Erysipelas. A retrospective series of 92 patients in a department of internal medicine Ann Med Intern 151 2000 3-9 [in French]
6. J.M. Bonnetblanc C. Bedane Erysipelas: Recognition and management Am J Clin Dermatol 4 2003 157-63
7. J. Smolle P. Kahofer E. Pfaffentaler H. Kerl Risk factors for local complications in erysipelas Hautarzt 51 2000 14-8 [in German]
8. R. Jaussaud E. Kaeppler C. Strady I. Beguinot A. Waldner G. Remy Should NSAID/corticoids be considered when treating erysipelas? Ann Dermatol Venereol 128 2001 348-51 [in French]
9. N.L. Browse G. Stewart Lymphoedema: Pathophysiology and classification J Cardiovasc Surg 26 1985 91-106
10. B. Becq-Giraudon Primary and secondary prevention for erysipelas Ann Dermatol Venereol 128 2001 368-75 [in French]
11. G. Bertelli M. Venturini G. Forno F. Macchiavello D. Dini An analysis of prognostic factors in response to conservative treatment of postmastectomy lymphedema Surg Gynecol Obstet 175 1992 455-60
12. G.F. Schwartz Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: Current update Breast J 10 2004 85-8